ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry

Host cell proteins (HCPs) must be adequately removed from recombinant therapeutics by downstream processing to ensure patient safety, product quality, and regulatory compliance. HCP process clearance is typically monitored by enzyme-linked immunosorbent assay (ELISA) using a polyclonal reagent. Rece...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:MAbs
Hoofdauteurs: Henry, Scott M., Sutlief, Elissa, Salas-Solano, Oscar, Valliere-Douglass, John
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2017
Onderwerpen:
Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627587/
https://ncbi.nlm.nih.gov/pubmed/28708446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1349586
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items